Table 4 Detailed information analysis of the patients’ sample, with one comorbidity
HIV+ mono-infected patients N = 251 | HIV/HCV co-infected patients N = 200 | p-value and Chi-squared | ||
|---|---|---|---|---|
Cardiovascular comorbidity | Mean Age [y] | 53.22 | 51.80 | > 0.050 |
Male gender | 78.05% | 84.52% | > 0.050 | |
Years with HIV [y] | 12.89 | 23.21 | < 0.001 | |
Neurocognitive impairments | Mean Age [y] | 42.13 | 50.78 | < 0.001 |
Male gender | 97.78% | 85.19% | 0.042 | |
Years with HIV [y] | 7.58 | 21.63 | < 0.001 | |
HBV | Mean Age [y] | 46.40 | 50.11 | > 0.050 |
Male gender | 100.00% | 100.00% | NA | |
Years with HIV [y] | 18.40 | 23.00 | > 0.050 | |
Bone events | Mean Age [y] | 43.43 | 51.31 | < 0.001 |
Male gender | 71.43% | 73.77% | > 0.050 | |
Years with HIV [y] | 10.71 | 24.95 | < 0.001 | |
Renal events | Mean Age [y] | 41.83 | 53.75 | 0.014 |
Male gender | 66.67% | 75.00% | > 0.050 | |
Years with HIV [y] | 11.17 | 20.75 | > 0.050 | |
Diabetes | Mean Age [y] | 44.33 | 54.40 | 0.002 |
Male gender | 100.00% | 73.33% | > 0.050 | |
Years with HIV [y] | 14.00 | 22.93 | > 0.050 | |